Taken together, the decreased levels of MAGP-1 in patients with obesity and CC as well as its capacity to modulate key genes involved in ECM remodelling and tumorigenesis suggest that MAGP-1 may be an important link between AT excess and CC development (Figure 5). This evidence concerns the gene MFAP2 and ataxia telangiectasia.